share_log

普利制药:关于盐酸去氧肾上腺素注射液获得美国食品药品监督管理局(FDA)上市许可的公告

Puri Pharmaceuticals: Announcement on obtaining marketing approval from the US Food and Drug Administration (FDA) for phenylephrine hydrochloride injections

深证信a股 ·  Mar 18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more